Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
about
Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issuesTrichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells.The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65.Long-term survival and intracellular replication of Mycoplasma hominis in Trichomonas vaginalis cells: potential role of the protozoon in transmitting bacterial infectionUse of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimensChemical structure of Trichomonas vaginalis surface lipoglycan: a role for short galactose (β1-4/3) N-acetylglucosamine repeats in host cell interactionProteome analysis of the surface of Trichomonas vaginalis reveals novel proteins and strain-dependent differential expression.Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells.Novel core promoter elements and a cognate transcription factor in the divergent unicellular eukaryote Trichomonas vaginalisLeukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis.Parasites and malignancies, a review, with emphasis on digestive cancer induced by Cryptosporidium parvum (Alveolata: Apicomplexa).Iron and contact with host cells induce expression of adhesins on surface of Trichomonas vaginalisSilencing the ap65 gene reduces adherence to vaginal epithelial cells by Trichomonas vaginalis.Symbiotic Association with Mycoplasma hominis Can Influence Growth Rate, ATP Production, Cytolysis and Inflammatory Response of Trichomonas vaginalisEpidemiology and treatment of trichomoniasis.Multiple HPV infections in female sex workers in Western Kenya: implications for prophylactic vaccines within this sub population.Trichomonas vaginalis infection: can we afford to do nothing?Neutrophils kill the parasite Trichomonas vaginalis using trogocytosis.
P2860
Q27025282-8B0871AC-4C12-497F-B1DF-A8C3ADA7517CQ33214943-BAF9811E-6F95-4108-AED3-ED7B8043D89FQ33288735-F181CCBA-1A6F-464C-A013-39E2E545CEE5Q33793866-BE6389F0-E516-4B77-802D-AC6C2527E732Q33824751-209EEC4B-AFCA-44BE-AE67-1A12ED1B5C42Q34013409-C5FE69BB-1512-4A97-80B6-E69426196C5DQ34122101-369AB7D4-A201-4CAD-A61D-4FE25715C29AQ35073960-CDD81D87-D428-492C-8701-649B01303B41Q35102056-D1DC7D0A-3FDF-440E-BCA8-A3E945C9E557Q36105015-53B266C4-3927-46D3-874C-36AA939C83EFQ36899190-4BFB5631-6F47-4743-B7F5-E2A9508E4921Q36925609-F9741F3B-D31D-4D40-836D-8204612F0227Q36925636-50D9DD87-C62D-4479-A67F-59CD5785D26DQ37018927-0BD67AFA-025E-4C2A-B5DA-8CBADF8E91EDQ37270533-33AA4714-5D39-4A55-84EA-473C6593960DQ37566009-91018356-FB90-405D-A5FF-8ABBAC11816CQ43076744-BB4317A2-9925-4734-8EE5-4F76E5F3211EQ50162422-0F06F641-4B55-433C-B734-3471A07613E8
P2860
Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
@ast
Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
@en
type
label
Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
@ast
Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
@en
prefLabel
Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
@ast
Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
@en
P2093
P2860
P356
P1476
Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients
@en
P2093
P2860
P304
P356
10.1136/STI.71.6.402
P577
1995-12-01T00:00:00Z